Sun Pharma shines on reporting 7% rise in Q4 consolidated net profit

28 May 2018 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 497.00, up by 30.45 points or 6.53% from its previous closing of Rs. 466.55 on the BSE.

The scrip opened at Rs. 487.70 and has touched a high and low of Rs. 497.30 and Rs. 481.70 respectively. So far 227470 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 608.55 on 12-Feb-2018 and a 52 week low of Rs. 433.15 on 14-Aug-2017.

Last one week high and low of the scrip stood at Rs. 498.50 and Rs. 434.80 respectively. The current market cap of the company is Rs. 111940.48 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.55% and 13.07% respectively.

The company has reported a rise of 83.30% in its net profit at Rs 176.26 crore for the quarter ended March 31, 2018 as compared to Rs 96.16 crore for the same quarter in the previous year. Total income of the company increased by 21.08% at Rs 2460.07 crore for quarter under review as compared to Rs 2031.74 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported a rise of 6.97% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 1308.96 crore for the quarter ended March 31, 2018 as compared to Rs 1223.71 crore for the corresponding quarter in the FY17. However, total consolidated income of the company decreased by 1.11% at Rs 7279.85 crore for quarter under review as compared to Rs 7361.46 crore for the same quarter ended previous year.

For the year ended March 31, 2018, the company has posted a net loss of Rs 494.59 crore as compared to net loss of Rs 22.84 crore for the previous year. However, total income of company increased by 9.24% at Rs 9075.64 crore for year under review as compared to Rs 8308.28 crore for the year ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted a fall of 68.96% in its net profit after taxes, share of profit/ (loss) of associates and joint ventures and non- controlling interests at Rs 2161.55 crore as compared to Rs 6964.37 crore for the same period in the previous year. Total income of company decreased by 15.13% at Rs 27328.22 crore for year under review as compared to Rs 32201.59 crore for the year ended March 31, 2017.

Sun Pharma Inds. Share Price

1589.30 -20.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×